July 26, 2024 Experience PGE $400 million at-the-market offering The common stock is listed on the NYSE
July 19, 2024 Experience Clariane €92 million reserved capital increase and €237 million rights offering We advised Clariane on its refinancing transactions
July 11, 2024 Experience IDEAYA Biosciences $302.5 million equity offering The common stock is listed on the Nasdaq Global Select Market
July 2, 2024 Experience Recursion Pharmaceuticals $230 million follow-on offering The shares are listed on the Nasdaq Global Select Market
July 2, 2024 Experience InflaRx $75 million at-the-market offering The shares are listed on the Nasdaq Global Market
July 2, 2024 Experience CCC Intelligent Solutions Holdings $339 million secondary offering The shares are listed on the Nasdaq Global Select Market
June 28, 2024 Experience Pepkor Holdings ZAR 9 billion secondary offering The accelerated bookbuild transaction represented approximately 13.6% of Pepkor’s issued share capital